RSI Alert: Puma Biotechnology (PBYI) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Tuesday, shares of Puma Biotechnology, Inc. ( PBYI) entered into oversold territory, hitting an RSI reading of 29.8, after changing hands as low as $35.0817 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 60.3. A bullish investor could look at PBYI's 29.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of PBYI shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Puma Biotechnology, Inc. 1 Year Performance Chart

Looking at the chart above, PBYI's low point in its 52 week range is $16.08 per share, with $62.66 as the 52 week high point — that compares with a last trade of $35.25.

null

If you liked this article you might like

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

5 New Breast Cancer Treatments That Are Helping to Save Lives

Puma Up as Breast Cancer Program Gets Green Light; Nektar's Oxycodon Comp. Gets Praise

Thursday's 'Triathlon of Terror' Is Overblown: Cramer's 'Mad Money' Recap (Wednesday 6/7/17)